Gvs Logo

Gvs

ISIN: IT0005411209 | Ticker: GVS | LEI: 81560013EACB40B52D17
Sector: Health CareSub-Industry: Health Care Supplies
Country: Italy

About Gvs

Company Description

GVS Group is one of the world’s leading manufacturers of filter solutions for applications in the Healthcare & Life Sciences, Energy & Mobility, and Health & Safety sectors.

In over 40 years of history, GVS has evolved from a supplier of components for the healthcare sector to a global Group that produces highly technological diversified filtration solutions.
The Group has always paid great attention to research, development and innovation of its products and processes and has shown a strong trend towards development in global markets since its foundation.

In addition to the Corporate headquarters in Bologna, GVS currently has 15 plants in Italy, United Kingdom, Brazil, United States, China, Malaysia, Mexico, Romania e Puerto Rico, and 18 commercial offices located all over the world.

GVS has always adopted a “glocal” approach: it operates locally in contact with its customers, but relies on the strength of a global network.

Year founded

1979

Served area

Worldwide

Headquarters

Via Roma 50, 40069 Zola Predosa – Italy

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Other Noncurrent Receivables N/A 0.00 1,695,000.00
Noncurrent Derivative Financial Assets 0.00 123,000.00 6,648,000.00
Cash and cash equivalents 125,068,000.00 136,893,000.00 135,169,000.00
Noncurrent Financial Liabilities At Amortised Cost 69,728,000.00 180,164,000.00 10,989,000.00
Noncurrent Derivative Financial Liabilities 107,000.00 0.00 N/A
Current Contract Liabilities 4,894,000.00 3,417,000.00 7,224,000.00
Current Financial Liabilities At Amortised Cost 19,673,000.00 41,706,000.00 438,238,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Contracts With Customers 363,296,000.00 338,126,000.00 387,591,000.00
Services Expense 36,216,000.00 36,662,000.00 54,573,000.00
Profit (loss) 78,083,000.00 67,604,000.00 24,120,000.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 78,083,000.00 67,604,000.00 24,120,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 69,569,000.00 7,954,000.00 -1,527,000.00
Cash and cash equivalents 125,068,000.00 136,893,000.00 135,169,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ITA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

IT0005411209

LEI

81560013EACB40B52D17

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.